View Featured Offers >>
79884
Lung Cancer RTK Antibody Sampler Kit
Primary Antibodies
Antibody Sampler Kit

Lung Cancer RTK Antibody Sampler Kit #79884

Reviews ()
Citations (0)
Lung Cancer RTK Antibody Sampler Kit: Image 1
Western blot analysis of extracts from various cell lines using Ret (E1N8X) XP® Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower).
Lung Cancer RTK Antibody Sampler Kit: Image 2
Western blot analysis of extracts from various EGFR expressing cell lines, showing the specificity of detection of mutant EGFR (E746-A750del) protein, using EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb (upper), and total EGFR control antibody (lower).
Lung Cancer RTK Antibody Sampler Kit: Image 3
Western blot analysis of extracts from various EGFR expressing cell lines, showing the specificity of detection of mutant EGFR (L858R) protein using EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb (upper), and total EGFR control antibody (lower).
Lung Cancer RTK Antibody Sampler Kit: Image 4
Western blot analysis of extracts from HCC78 (SLC34A2-ROS1), U-118 MG (FIG-ROS1), and HeLa (ROS1 negative) cells using ROS1 (D4D6®) Rabbit mAb (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower). Note: HCC78 cells express the 85, 70, and 59 kDa forms of the SLC34A2-ROS1 fusion protein (7).
Lung Cancer RTK Antibody Sampler Kit: Image 5
Western blot analysis of extracts from NCI-H2228 and NCI-H3122 cells using ALK (D5F3®) XP® Rabbit mAb. Variants denoting fusions of different EML4 exons (v1 or v3) are indicated.
Lung Cancer RTK Antibody Sampler Kit: Image 6
Western blot analysis of extracts from control Hela cells (lane 1), or EGFR knockout Hela cells (lane 2) using EGF Receptor (D38B1) XP® Rabbit mAb #4267, (upper) or #8457 β-Actin (D6A8) Rabbit mAb (lower). The absence of signal in EGFR-knockout Hela cells confirms specificity of the antibody for EGFR.
Lung Cancer RTK Antibody Sampler Kit: Image 7
Western blot analysis of extracts from SK-BR-3 and MCF7 cells using HER2/ErbB2 (D8F12) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 8
After the primary antibody is bound to the target protein, a complex with HRP-linked secondary antibody is formed. The LumiGLO® is added and emits light during enzyme catalyzed decomposition.
Lung Cancer RTK Antibody Sampler Kit: Image 9
Western blot analysis of extracts from HT-29 (Met+), SK-BR-3 (Met-), and T-47D (Met-) cells using Met (D1C2) XP® Rabbit mAb (upper) or β-Actin Antibody #4967 (lower).
Lung Cancer RTK Antibody Sampler Kit: Image 10
Western blot analysis of extracts from A-204 (FGFR1 positive), KG-1a (FGFR1 oncogenic partner-FGFR1 fusion), A172 (FGFR1 low), and HT-29 (FGFR1 negative) cells using FGF Receptor 1 (D8E4) XP® Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower).
Lung Cancer RTK Antibody Sampler Kit: Image 11
Immunohistochemical analysis of paraffin-embedded human adrenal gland using Ret (E1N8X) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 12
Immunohistochemical analysis of paraffin-embedded H1975 (left, EGFR L858R positive) and H1650 xenografts (right, EGFR deletion positive) using EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb (upper) and total EGFR (D38B1) XP® Rabbit mAb #4267 (lower).
Lung Cancer RTK Antibody Sampler Kit: Image 13
Western blot analysis of extracts from 293T cells, mock transfected (-) or transfected with a construct expressing wildtype ROS1 (hROS1; +), using ROS1 (D4D6®) Rabbit mAb (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower).
Lung Cancer RTK Antibody Sampler Kit: Image 14
Immunohistochemical analysis of paraffin-embedded human lung carcinoma with high (left) and low levels (right) of ALK expression using ALK (D5F3®) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 15
Western blot analysis of extracts from A-431, BxPC3 and HeLa cells using EGF Receptor (D38B1) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 16
Immunohistochemical analysis of paraffin-embedded human urothelial carcinoma using HER2/ErbB2 (D8F12) XP® Rabbit mAb performed on the Leica® BOND Rx. 
Lung Cancer RTK Antibody Sampler Kit: Image 17
Western blot analysis of extracts from control HeLa cells (lane 1) or Met knockout HeLa cells (lane 2) using Met (D1C2) XP® Rabbit mAb #8198. The absence of signal in the Met knockout HeLa cells confirms specificity of the antibody for Met.
Lung Cancer RTK Antibody Sampler Kit: Image 18
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using FGF Receptor 1 (D8E4) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 19
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using Ret (E1N8X) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 20
Immunohistochemical analysis of paraffin embedded human lung carcinoma of known mutational status using EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb (upper) and total EGFR (D38B1) XP® Rabbit mAb #4267 (lower). EGFR L858R positive lung (left), EGFR deletion positive lung sections (right).
Lung Cancer RTK Antibody Sampler Kit: Image 21
Immunoprecipitation of ROS1 from HCC78 cell extracts using Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (lane 2) or ROS1 (D4D6®) Rabbit mAb (lane 3). Lane 1 is 10% input. Western blot analysis was performed using ROS1 (D4D6®) Rabbit mAb, followed by Mouse Anti-rabbit IgG (Conformation Specific) (L27A9) mAb #3678 and Anti-mouse IgG, HRP-linked Antibody #7076.
Lung Cancer RTK Antibody Sampler Kit: Image 22
Immunohistochemical analysis of paraffin-embedded anaplastic large cell lymphoma (ALCL) using ALK (D5F3®) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 23
Immunoprecipitation of EGF Receptor from HeLa cell extracts using rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (lane 2) or EGF Receptor (D38B1) XP® Rabbit mAb #4267 (lane 3). Lane 1 is 10% input. Western blot analysis was performed using EGF Receptor (D38B1) XP® Rabbit mAb #4267. Anti-rabbit IgG, HRP-linked Antibody #7074 was used for detection.
Lung Cancer RTK Antibody Sampler Kit: Image 24
Immunohistochemical analysis of paraffin-embedded human urothelial carcinoma using HER2/ErbB2 (D8F12) XP® Rabbit mAb performed on the Leica® BOND Rx. 
Lung Cancer RTK Antibody Sampler Kit: Image 25
Immunohistochemical analysis of paraffin-embedded human colon adenocarcinoma using Met (D1C2) XP® Rabbit mAb performed on the Leica® Bond Rx.
Lung Cancer RTK Antibody Sampler Kit: Image 26
Immunohistochemical analysis of paraffin-embedded human kidney using FGF Receptor 1 (D8E4) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 27
Immunohistochemical analysis of paraffin-embedded human small intestine using Ret (E1N8X) XP® Rabbit mAb. Note the positive signal of the myenteric plexus in the muscularis externa of the small intestine.
Lung Cancer RTK Antibody Sampler Kit: Image 28
Immunohistochemical analysis of paraffin-embedded H1975 (left, EGFR L858R positive) and H1650 xenograft (right, EGFR deletion positive) using EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb (upper) and total EGFR (D38B1) XP® Rabbit mAb #4267 (lower).
Lung Cancer RTK Antibody Sampler Kit: Image 29
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using ROS1 (D4D6®) Rabbit mAb. Note: Staining is of FIG-ROS1 fusion (6).
Lung Cancer RTK Antibody Sampler Kit: Image 30
Immunohistochemical analysis of paraffin-embedded human non-small cell lung carcinoma using ALK (D5F3®) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 31
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using EGF Receptor (D38B1) Rabbit mAb performed on the Leica® BOND Rx.
Lung Cancer RTK Antibody Sampler Kit: Image 32
Immunohistochemical analysis of paraffin-embedded human lung adenocarcinoma using HER2/ErbB2 (D8F12) XP® Rabbit mAb performed on the Leica® BOND Rx. 
Lung Cancer RTK Antibody Sampler Kit: Image 33
Immunohistochemical analysis of paraffin-embedded human non-small cell lung carcinoma using Met (D1C2) XP® Rabbit mAb performed on the Leica® Bond Rx.
Lung Cancer RTK Antibody Sampler Kit: Image 34
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using FGF Receptor 1 (D8E4) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 35
Immunohistochemical analysis of paraffin-embedded TT (left) or Hep G2 (right) cell pellets using Ret (E1N8X) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 36
Immunohistochemical analysis of paraffin-embedded human lung carcinoma of known mutational status using EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb (upper) and total EGFR (D38B1) XP® Rabbit mAb #4267 (lower). EGFR L858R positive lung (left), EGFR deletion positive lung sections (right).
Lung Cancer RTK Antibody Sampler Kit: Image 37
Immunohistochemical analysis of paraffin-embedded human lung carcinomas showing distinct localization using ROS1 (D4D6®) Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 38
Immunohistochemical analysis of paraffin-embedded MDA-MB-468 (amplified EGFR, left), HT-29 (low EGFR, middle) and CAMA-1 (EGFR negative, right) cells using EGF Receptor (D38B1) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 39
Immunohistochemical analysis of paraffin-embedded human prostate carcinoma using HER2/ErbB2 (D8F12) XP® Rabbit mAb performed on the Leica® BOND Rx. 
Lung Cancer RTK Antibody Sampler Kit: Image 40
Immunohistochemical analysis of paraffin-embedded human metastatic lung carcinoma using Met (D1C2) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 41
Confocal immunofluorescent analysis of TT (positive, left) and HeLa (negative, right) cells using Ret (E1N8X) XP® Rabbit mAb (green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 42
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using ROS1 (D4D6®) Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 43
Immunohistochemical analysis of paraffin-embedded human hepatocellular carcinoma using EGF Receptor (D38B1) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 44
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using HER2/ErbB2 (D8F12) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 45
Immunohistochemical analysis of paraffin-embedded human hepatocellular carcinoma using Met (D1C2) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 46
Confocal immunofluorescent analysis of A204 cells (positive, left), KG-1 cells (positive, middle) and A172 cells (weak expression, right) using FGF Receptor 1 (D8E4) XP® Rabbit mAb (green). Blue pseudocolor= DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 47
Flow cytometric analysis of fixed and permeabilized HeLa cells (blue, negative) and TT cells (green, positive) using Ret (E1N8X) XP® Rabbit mAb (solid lines) or concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (dashed lines). Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) #4412 was used as a secondary antibody.
Lung Cancer RTK Antibody Sampler Kit: Image 48
Immunohistochemical analysis of paraffin-embedded HCC78 xenograft using ROS1 (D4D6®) Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 49
Flow cytometric analysis of U-937 cells (blue) and KARPAS 299 cells (green) using ALK (D5F3®) XP® Rabbit mAb (solid lines) or a concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (dashed lines). Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) #4412 was used as a secondary antibody.
Lung Cancer RTK Antibody Sampler Kit: Image 50
Immunohistochemical analysis of paraffin-embedded human placenta using EGF Receptor (D38B1) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 51
Immunohistochemical analysis of paraffin-embedded human ductal breast carcinoma using HER2/ErbB2 (D8F12) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 52
Immunohistochemical analysis of paraffin-embedded human papillary renal cell carcinoma using Met (D1C2) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 53
Flow cytometric analysis of fixed and permeabilized A-204 cells using FGF Receptor 1 (D8E4) XP® Rabbit mAb (blue) compared to concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (red). Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) #4412 was used as a secondary antibody.
Lung Cancer RTK Antibody Sampler Kit: Image 54
Confocal immunofluorescent analysis of HCC78 (left) or HeLa (right) cells using ROS1 (D4D6®) Rabbit mAb (green). Actin filaments were labeled with DY-554 phalloidin (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 55
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using EGF Receptor (D38B1) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 56
Immunohistochemical analysis of paraffin-embedded SK-BR-3 (Her2 high, left) and MCF7 cell pellets (Her2 low, right) using HER2/ErbB2 (D8F12) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 57
Immunohistochemical analysis of paraffin-embedded cell pellets, MKN-45 (left) and T-47D (right), using Met (D1C2) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 58
Confocal immunofluorescent analysis of paraffin-embedded H3255, H1975, HCC827 and H1650 xenografts using EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb (upper, green) and EGFR (D38B1) XP® Rabbit mAb #4267 (lower, green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 59
Flow cytometric analysis of HeLa cells (blue, negative) and HCC78 cells (green, positive) using ROS1 (D4D6®) Rabbit mAb (solid lines) or a concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (dashed lines). Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) #4412 was used as a secondary antibody.
Lung Cancer RTK Antibody Sampler Kit: Image 60
Confocal immunofluorescent analysis of A549 cells, untreated (left) or treated with human epidermal growth factor (right), using EGF Receptor (D38B1) XP® Rabbit mAb (green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 61
Confocal immunofluorescent analysis of HCC827, H1650 and Kyse450 cells using EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb (green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 62
Flow cytometric analysis of Jurkat cells (blue) and A431 cells (green) using EGF Receptor (D38B1) XP® Rabbit mAb #4267 (solid lines) or a concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (dashed lines). Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) #4412 was used as a secondary antibody.
Lung Cancer RTK Antibody Sampler Kit: Image 63
Confocal immunofluorescent analysis of HT-29 and T-47D cells using Met (D1C2) XP® Rabbit mAb (green). Actin filaments were labeled with DY-554 phalloidin (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 64
Confocal immunofluorescent analysis of paraffin-embedded H3255, H1975, HCC827 and H1650 xenografts using EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb (upper, green) and EGFR (D38B1) XP® Rabbit mAb #4267 (lower, green). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 65
Flow cytometric analysis of fixed and permeabilized Ramos cells (blue, negative) and MKN-45 cells (green, positive) using Met (D1C2) XP® Rabbit mAb (solid lines) or a concentration-matched Rabbit (DA1E) mAb IgG XP® Isotype Control #3900 (dashed lines). Anti-rabbit IgG (H+L), F(ab')2 Fragment (Alexa Fluor® 488 Conjugate) #4412 was used as a secondary antibody.
Lung Cancer RTK Antibody Sampler Kit: Image 66
Flow cytometric analysis of fixed and permeabilized Kyse450 cells (wildtype, blue) and HCC827 cells (exon 19 deletion (E746-A750del, green) using EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb.
Lung Cancer RTK Antibody Sampler Kit: Image 67
Confocal immunofluorescent analysis of H3255 (left), HCC827 (middle) and A431 cells (right) using EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb (green) and MEK1/2 (L38C12) Mouse mAb #4694 (red). H3255 cells have the L858R EGFR mutation, HCC827 cells have an exon 19 EGFR deletion, and A431 cells overexpress wild type EGFR. Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Lung Cancer RTK Antibody Sampler Kit: Image 68
Flow cytometric analysis of two non-small cell lung cancer cell lines using EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb. H3255 cells (green) harbor the L858R EGFR mutation while the H1650 cells (blue) have the exon 19 mutation (delE746-A750).
To Purchase # 79884
Cat. # Size Qty. Price
79884T
1 Kit  (9 x 20 microliters)
$ 780

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
EGF Receptor (D38B1) XP® Rabbit mAb 4267 20 µl
  • WB
  • IP
  • IHC
  • IF
  • F
H M Mk 175 Rabbit IgG
EGF Receptor (L858R Mutant Specific) (43B2) Rabbit mAb 3197 20 µl
  • WB
  • IP
  • IHC
  • IF
  • F
H 175 Rabbit IgG
EGF Receptor (E746-A750del Specific) (D6B6) XP® Rabbit mAb 2085 20 µl
  • WB
  • IP
  • IHC
  • IF
  • F
H 175 Rabbit IgG
ALK (D5F3®) XP® Rabbit mAb 3633 20 µl
  • WB
  • IP
  • IHC
  • F
H 220 (ALK), 80 (NPM-ALK), 117 (EML4-ALK v1), 86 (EML4-ALK v3) Rabbit IgG
HER2/ErbB2 (D8F12) XP® Rabbit mAb 4290 20 µl
  • WB
  • IHC
H M 185 Rabbit IgG
FGF Receptor 1 (D8E4) XP® Rabbit mAb 9740 20 µl
  • WB
  • IP
  • IHC
  • IF
  • F
H M R Mk 92 , 120, 145 Rabbit IgG
ROS1 (D4D6®) Rabbit mAb 3287 20 µl
  • WB
  • IP
  • IHC
  • IF
  • F
H 258, 110, 50-80 Rabbit IgG
Ret (E1N8X) XP® Rabbit mAb 14556 20 µl
  • WB
  • IHC
  • IF
  • F
H M 150, 175 Rabbit IgG
Met (D1C2) XP® Rabbit mAb 8198 20 µl
  • WB
  • IP
  • IHC
  • IF
  • F
H 140, 170 Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
  • WB
Goat 

Product Description

The Lung Cancer RTK Antibody Sampler Kit provides an economical means of detecting receptor tyrosine kinases (RTKs) associated with lung cancer. The kit includes enough antibodies to perform two western blot experiments with each primary antibody.

Specificity / Sensitivity

Each antibody in the Lung Cancer RTK Antibody Sampler Kit detects endogenous levels of its target protein. FGF Receptor 1 (D8E4) XP® Rabbit mAb may slightly cross-react with overexpressed FGF receptor family members. IHC staining for ROS1 (D4D6®) Rabbit mAb may be observed in ROS1 rearranged lung carcinomas, macrophages/giant cells, reactive type II pneumocyte hyperplasia, and the epithelium in areas of bronchiolar metaplasia. Staining of unknown specificity has been observed in cholangiocarcinoma, hepatocellular carcinoma, and kidney tissues. HER2/ErbB2 (D8F12) XP® Rabbit mAb may cross-react slightly with other overexpressed RTKs. EGF Receptor (D38B1) XP® Rabbit mAb does not cross-react with other proteins of the ErbB family. Species cross-reactivity for IHC-P, IHC-BOND, and IF-IC is human only. EGFR (L858R Mutant Specific) (43B2) Rabbit mAb may cross-react with wild-type EGFR and other HER family members when highly overexpressed. Careful titration of this antibody may be required to obtain optimal specificity.

Source / Purification

Monoclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding E746-A750del and L865 mutant sequences of human EGFR, Pro320 of human Ret protein, and residues near the carboxy terminus of human Met protein, or recombinant proteins specific to the carboxy terminus of human FGF receptor 1, human ALK, human ROS1, the amino terminus of human HER2/ErbB2, and the cytoplasmic domain of human EGF receptor.

Background

Lung cancer is the leading cause of cancer-related mortality worldwide (1). It is generally divided into two broad histological classifications: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC comprises about 80-85% of all lung cancers. Receptor tyrosine kinases (RTKs) are essential components to cellular signaling pathways and are often overexpressed or otherwise dysregulated by genetic mutations, fusion, or gene amplification (2,3). RTKs are generally activated by receptor specific ligands, leading to autophosphorylation and the subsequent recruitment of downstream signaling proteins. The most common RTK amplification in NSCLC is that for epidermal growth factor receptor (EGFR). Also, two of the most common mutations in EGFR include an exon 19 deletion, E746-A750, and a point mutation L858R (4,5). In addition to EGFR, several other RTKs may become aberrantly activated in NSCLC, including ALK, ROS1, HER2/ErbB2, Met, Ret, FGF Receptor 1, and NTRK (6). Specific tyrosine kinase inhibitors (TKIs) have been part of the arsenal of treating the disease and so analyzing the expression and mutational status of these receptors plays an important role in personalized treatment.  
  1. Sung, H. et al. (2021) CA Cancer J Clin 71, 209-249.
  2. Reinmuth, N. et al. (2006) Int J Cancer 119, 727-34.
  3. Du, Z. and Lovly, C.M. (2018) Mol Cancer 17, 58.
  4. Kosaka, T. et al. (2004) Cancer Res 64, 8919-23.
  5. Riely, G.J. et al. (2006) Clin Cancer Res 12, 7232-41.
  6. Rebuzzi, S.E. et al. (2021) Int J Mol Sci 22, 2625.

Pathways & Proteins

Explore pathways + proteins related to this product.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
D4D6 is a registered trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.
The manufacture, use, sale and import of this product is within the scope of one or more intellectual property rights (including patents and patent applications) owned or controlled by Cell Signaling Technology. The purchase of this product conveys to the buyer a non-transferrable right to use the purchased product only in research conducted by the buyer. The sale of the product is expressly conditioned on the buyer not using the products or its components (1) to analyze or reverse engineer the product for its chemical/physical properties and composition (including e.g., identification of the sequence); (2) in manufacturing; (3) to provide a service, information, or data to an unaffiliated third party for payment; (4) for therapeutic, diagnostic or prophylactic purposes; (5) resale, whether or not such product are resold for use in research; or for any other commercial purpose. For information on purchasing a license to this product for purposes other than research, contact Cell Signaling Technology, Inc. Business Development at [email protected]